Cyclacel Pharma (CYCC) Tops Q1 EPS by 20c
Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.47), $0.20 better than the analyst estimate of ($0.67).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.47), $0.20 better than the analyst estimate of ($0.67).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.